Agilent Technologies’ US$925 Million Acquisition of BioVectra

DLA Piper advised Agilent Technologies on the deal.Agilent Technologies, Inc. (Agilent), a global leader in life sciences, diagnostics and applied chemical markets, announced its proposed acquisition…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here